Skip to main content

Table 1 Characteristics of participants (N = 100)

From: Soluble cytotoxic T-lymphocyte–associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma

Feature No of cases (%)   Total
Patients Control
Overall 50 50 100
Gender
 Female 23 (46.0) 24 (48.0) 47 (47.0)
 Male 27 (54.0) 26 (52.0) 53 (53.0)
Age (years)
  ≤ 60 31 (62.0) 27 (54.0) 58 (58.0)
  > 60 19 (38.0) 23 (46.0) 42 (42.0)
Tobacco smoking
 Ever 17 (34.0) 19 (38.0) 36 (36.0)
 Never 33 (66.0) 31 (62.0) 64 (64.0)
Alcohol drinking
 Ever 15 (30.0) 18 (36.0) 33 (33.0)
 Never 35 (70.0) 32 (64.0) 67 (67.0)
Grade
 Low-grade glioma 24 (48.0)
 High-grade glioma 26 (52.0)
Tumor site
 Frontal lobe 15 (30.0)
 Temporal lobe 11 (22.0)
 Parietal lobe 6 (12.0)
 Occipital lobe 7 (14.0)
 Other 11 (22.0)
Ki-67 labeling index
 Negative (−) 10 (20.0)
 Weakly positive (+) 16 (32.0)
 Moderately positive (++) 14 (28.0)
 Strongly positive (+++) 10 (20.0)